NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
25.59
+0.67 (2.69%)
Sep 2, 2026, 4:00 PM EDT - Market closed
NAMS Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -259.5 | -203.82 | -241.6 | -176.94 | -22.63 | -41.79 |
Depreciation & Amortization | 0.24 | 0.22 | 0.11 | 0.05 | 0.01 | 0.01 |
Other Amortization | - | - | - | - | - | 0.16 |
Loss (Gain) From Sale of Assets | 0.03 | 0.01 | - | - | - | - |
Asset Writedown & Restructuring Costs | - | - | - | - | 8 | 7.22 |
Stock-Based Compensation | 65.42 | 59.43 | 33.62 | 24.57 | 4.12 | 1.24 |
Other Operating Activities | 39.27 | 4.32 | 81.98 | 5.23 | 10.8 | -0.82 |
Change in Accounts Payable | -0.43 | 4.91 | -12.95 | 5.07 | 4.81 | 6.56 |
Change in Unearned Revenue | 2.8 | -2.02 | -3.95 | -8.71 | 18.43 | - |
Change in Other Net Operating Assets | 8.72 | -10.83 | -15.77 | 9.5 | -12.86 | -2.09 |
Operating Cash Flow | -143.46 | -147.78 | -158.56 | -141.22 | 10.67 | -29.51 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.26 | -0.25 | -0.67 | -0.02 | -0.22 | -0.02 |
Investment in Securities | -34.65 | -174.67 | -62.18 | - | - | - |
Investing Cash Flow | -34.91 | -174.92 | -62.85 | -0.02 | -0.22 | -0.02 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | - | 0.75 | - |
Total Debt Issued | - | - | - | - | 0.75 | - |
Net Debt Issued (Repaid) | - | - | - | - | 0.75 | - |
Issuance of Common Stock | 41.68 | 31.11 | 661.04 | 8.91 | 396.95 | - |
Repurchase of Common Stock | - | - | -0.99 | - | - | - |
Other Financing Activities | - | -1.59 | -0.54 | - | -5.79 | - |
Financing Cash Flow | 41.68 | 29.52 | 659.51 | 8.91 | 391.91 | 84.7 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -1.67 | 12.76 | -6.8 | 5.05 | 5.25 | -4.68 |
Net Cash Flow | -138.36 | -280.42 | 431.29 | -127.28 | 407.6 | 50.49 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -143.72 | -148.03 | -159.24 | -141.24 | 10.44 | -29.54 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -2018.28% | -657.82% | -349.49% | -1002.43% | 10.17% | - |
Free Cash Flow Per Share | -1.19 | -1.25 | -1.69 | -1.72 | 0.55 | -2.69 |
Levered Free Cash Flow | -45.36 | -112.91 | -43.17 | -72 | 22.7 | -15.94 |
Unlevered Free Cash Flow | -45.36 | -112.91 | -43.17 | -72 | 22.88 | -15.84 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | - | - | 0.28 | - |
Cash Income Tax Paid | - | - | 0 | 0.03 | - | - |
Change in Working Capital | 11.09 | -7.94 | -32.67 | 5.87 | 10.37 | 4.47 |